Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cardiac ablation system and method for treatment of cardiac arrhthmias and transmyocardial revascularization

a technology of ablation system and transmyocardial revascularization, which is applied in the field of cardiac ablation system and method for treating cardiac arrhthmias and transmyocardial revascularization, can solve the problems of cardiac arrhythmia, rapid, uncontrolled, ineffective heart beating, and sudden cardiac death

Inactive Publication Date: 2006-09-28
WANG PAUL J +1
View PDF99 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Tachycardia is a type of cardiac arrhythmia and is a serious, often-times, fatal condition characterized by rapid, uncontrolled, and ineffective beating of the heart.
VT occurs in the lower chambers of the heart, the ventricles, and frequently leads to serious complications, including sudden cardiac death.
Atrial fibrillation and flutter, forms of SVT, originate in the upper chambers of the heart, the atria, and often result in chest pain, fatigue and dizziness and, while generally not life-threatening, is a leading cause of stroke in the United States.
However, the drugs do not eliminate or may not completely control the arrhythmia.
Concurrent treatment with drugs is standard therapy and each implantation of a cardiac defibrillator, of which there may be more than one per patient, is very expensive.
In atrial fibrillation the regular pumping action of the atria is replaced by a disorganized, ineffective quivering caused by chaotic conduction of electrical signals through the upper chambers of the heart.
Although not immediately life threatening, atrial fibrillation may cause up to a 30% reduction in cardiac output and can lead to more serious conditions, including the formation of blood clots in the atria that can dislodge and travel to the brain resulting in stroke.
Currently, the only curative treatment for atrial fibrillation is the surgical “maze procedure”, an open heart procedure in which the surgeon makes several incisions in the right and left atria creating scar tissue to electrically separate portions of the atria Despite clinical success of the maze procedure, it is time-consuming and demanding.
The procedure requires open heart surgery and is very expensive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cardiac ablation system and method for treatment of cardiac arrhthmias and transmyocardial revascularization
  • Cardiac ablation system and method for treatment of cardiac arrhthmias and transmyocardial revascularization
  • Cardiac ablation system and method for treatment of cardiac arrhthmias and transmyocardial revascularization

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0056] The heart as shown in FIG. 1 has at least two surfaces, an outer surface, the epicardium 20, and an inner surface, the endocardium 22. Numerous cardiac structures are identifiable on the epicardial surface 20. For example, as illustrated in FIGS. 2A and B, the pulmonary artery 24 and aorta 26 exit from the epicardial surface 20 at the base 28 of the heart. The apex 30 of the heart is the pointed end of the heart opposite the base 28 of the heart. The left atrium 32 and right atrium 34 are readily identifiable by the left 36 and right 38 auricles. The right ventricle 40 and left ventricle 42 are localized by identifying the left longitudinal groove 44 which runs from approximately the heart base 28 to apex 30 on the epicardial surface 20. The coronary groove 46 on the epicardial surface 20 separates the cardiac atria 32, 34 from the cardiac ventricles 42, 40. The great coronary vessels 48 are disposed in the coronary groove 46.

[0057] The endocardium 22 lines the inside walls ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A medical device, and related method, use epicardial ablators and detectors for intraoperative epicardial approaches to ablation therapy of cardiac conduction pathways. An epicardial gripper is sized to grasp the cardiac circumference or smaller structures on the epicardial surface of the heart. Ablators are disposed on the arms of the gripper for epicardial ablation of cardiac conduction tissue. In another embodiment of the invention, an electrode system includes a flexible, adjustable probe forming a loop for epicardial ablation. Ablators are provided on one or multiple surfaces of the probe for epicardial ablation of cardiac conduction tissue. In yet another embodiment of the invention, an endocardial ablator detection system provides an indicator adjacent an ablator on an endocardial catheter, and a detector on an epicardial probe. The epicardial probe detects signals transmitted by the indicator on the endocardial catheter to localize the position of the endocardial ablator relative to the epicardial surface. The surgeon uses this information for guidance in adjusting the position of the endocardial ablator according to therapeutic objectives of cardiac ablation.

Description

[0001] This application is a continuation of application Ser. No. 10 / 695,110, filed on Oct. 28, 2003 (to issue as U.S. Pat. No. 7,041,095) which is a continuation of U.S. application Ser. No. 10 / 032,302, filed on Dec. 21, 2001, now abandoned, which is a continuation of U.S. application Ser. No. 09 / 082,047, filed on May 20, 1998 (now U.S. Pat. No. 6,527,767). The entire disclosures of the foregoing patents and applications are hereby incorporated by reference.BACKGROUND OF THE INVENTION [0002] Tachycardia is a type of cardiac arrhythmia and is a serious, often-times, fatal condition characterized by rapid, uncontrolled, and ineffective beating of the heart. Most tachycardia is one of two broad categories: ventricular tachycardia (hereinafter VT) and supraventricular tachycardia (hereinafter SVT). VT occurs in the lower chambers of the heart, the ventricles, and frequently leads to serious complications, including sudden cardiac death. Atrial fibrillation and flutter, forms of SVT, or...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61B18/04A61B18/02A61B18/14
CPCA61B18/1442A61B18/1445A61B2017/2945A61B2018/0212A61B2018/0225A61B2018/0262A61B2018/1432A61B2018/1467
Inventor WANG, PAUL J.RASTEGAR, HASSAN
Owner WANG PAUL J
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products